Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
Cancer Research and Treatment|May 4, 2023
ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract CancerSung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, et al.Asia-Pacific Journal of Clinical Oncology|January 3, 2013
Changing treatment patterns in elderly patients with resectable colon cancerGun Min Kim, Joong Bae Ahn, Sun Young Rha, et al.Journal for Immunotherapy of Cancer|November 17, 2020
Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancerYu Seong Lee, Won Suk Lee, Chang Woo Kim, et al.Journal of Pain and Symptom Management|May 17, 2021
Development of a One-item Screening Question to Assess Spiritual Well-Being for Advanced Cancer Inpatients in KoreaYoungmin Park, Sang-Yeon Suh, Sun-Hyun Kim, et al.Therapeutic Advances in Medical Oncology|July 21, 2022
The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinomaHan Sang Kim, Chang Gon Kim, Jung Yong Hong, et al.Liver Cancer|February 12, 2024
Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular CarcinomaYoung Shin Song, Hannah Yang, Beodeul Kang, et al.Journal of Pain and Symptom Management|September 12, 2018
Spiritual Well-being Among Palliative Care Patients With Different Religious Affiliations: A Multicenter Korean StudySeok Joon Yoon, Sang-Yeon Suh, Sun Hyun Kim, et al.Oncoimmunology|December 3, 2021
Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathwayJeong Hun Kim, Won Suk Lee, Hye Jin Lee, et al.JHEP Reports : Innovation in Hepatology|March 3, 2023
High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinomaHannah Yang, Beodeul Kang, Yeonjung Ha, et al.Cancer Research and Treatment|April 20, 2019
Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal CarcinomaJii Bum Lee, Hyung Soon Park, Sejung Park, et al.Pageof 10